Two Versions: May 21 & May 24 [BE/BA News]
❝ But IS variations could be considered an assignable cause for analytical repeats.
Yes it is, but I think there is need to determine assignable cause for IS variations.
❝ I noticed there are two versions of the guidance on the internet. One is dated May 21, 2018 while the other is May 24, 2018.
❝ Could it be that the May 24 version is the updated and thus the recommended version to use? Was also wondering what was the modification done
I have skimmed through both documents. I did not notice any difference except for a very negligible formatting difference: the May 24 document seemed a bit narrower.
If they are same, I wonder what the FDA did on the document for it to change from a size of 373KB to 386KB. I also wonder why the update if there were no changes made. My pondering continues


—
Scopy
Scopy
Complete thread:
- New FDA BMV guideline Ohlbe 2018-05-21 16:28 [BE/BA News]
- What a monster! Helmut 2018-05-21 17:47
- What a monster! jag009 2018-05-24 03:19
- Two Versions: May 21 & May 24 Obinoscopy 2018-07-29 18:13
- What a monster! jag009 2018-05-24 03:19
- Repeats as part of investigations, ja oder nein? ElMaestro 2018-05-22 00:17
- Repeats as part of investigations, ja oder nein? Ohlbe 2018-05-22 12:02
- Two Versions: May 21 & May 24Obinoscopy 2018-07-30 20:41
- Requirements ⇒ recommendations Helmut 2018-08-01 11:12
- Requirements ⇒ recommendations Obinoscopy 2018-08-02 22:59
- Requirements ⇒ recommendations Helmut 2018-08-01 11:12
- Two Versions: May 21 & May 24Obinoscopy 2018-07-30 20:41
- Repeats as part of investigations, ja oder nein? Ohlbe 2018-05-22 12:02
- What a monster! Helmut 2018-05-21 17:47